6 Results for "

PSMA-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "PSMA-IN-3" in MCE Product Catalog:

Cat. No.: HY-149869
CAS No.: 2941187-68-2
Target:  

PSMA

Research Areas:  

Cancer

PSMA-IN-3 (compound 17) is a novel high-affinity PSMA inhibitor with an IC50 value of 13 nM. PSMA-IN-3 is suitable for developing an 18F-labeled radioligand for PET imaging of PSMA in prostate cancer .
loading...
    loading...
Cat. No.: HY-179051
CAS No.: 2756661-48-8
Research Areas:  

Cancer

PSMA ligand 3 is a PSMA-targeting ligand of Psa-AR (HY-179056). Psa-AR can be used for cancer research .
loading...
    loading...
Cat. No.: HY-161626
CAS No.: 3049900-51-5
Target:  

PSMA

Research Areas:  

Cancer

PSMA binder-3 is a binder of PSMA.
loading...
    loading...
Cat. No.: HY-P991757

Target:  

PSMA

Research Areas:  

Cancer

Anti-Human/Mouse/Rat/Canine/Swine PSMA Antibody (3F11) reacts with prostate-specific membrane antigen (PSMA) from human, mouse, rat, canine and swine species. Recommend Isotype Controls: Mouse IgG1 kappa, Isotype Control (HY-P99977) .
loading...
    loading...
Cat. No.: HY-P11488
JR11-PEG3-DOTA-PSMA-03 (Compound 2) is an RDC-related compound containing the chelating agent DOTA (HY-W053583), the JR11 peptide (SSTR2 antagonist), and the PSMA ligand. JR11-PEG3-DOTA-PSMA-03 shows SSTR2-binding affinities and PSMA-binding affinities, with IC50 s of 94.0 nM, 81.8 nM, respectively. JR11-PEG3-DOTA-PSMA-03 can be radiolabeled with [ 68Ga]. [ 68Ga] radiolabeled JR11-PEG3-DOTA-PSMA-03 can be used in diagnostic studies of neuroendocrine differentiated prostate cancer .
loading...
    loading...
Cat. No.: HY-P11485
JR11-PEG3-HBED-CC-PSMA-03 (Compound 1) is an RDC-related compound containing the chelating agent HBED-CC, the JR11 peptide (SSTR2 antagonist), and the PSMA ligand. JR11-PEG3-HBED-CC-PSMA-03 shows SSTR2-binding affinities and PSMA-binding affinities, with IC50 s of 59.2 nM, 57.0 nM, respectively. JR11-PEG3-HBED-CC-PSMA-03 can be radiolabeled with [ 68Ga]. [ 68Ga] radiolabeled JR11-PEG3-HBED-CC-PSMA-03 can be used in diagnostic studies of neuroendocrine differentiated prostate cancer .
loading...
    loading...